Changes in clinical and biochemical characteristics at 24 months by study group.

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (OG4C3) units for treatment arms over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (...

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV during six months of therapy.

Yi-Hua Lin (4385788)
Xi-Ning Liao (4385794)
Li-Li Fan (4385791)
Yue-Jin Qu (4385797)
De-Yun Cheng (4385800)
Yong-Hong Shi (4385803)

August 2017

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV duri...

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.

Concetta Irace (739030)
Antonio Cutruzzolà (6425195)
Delia Francesca Carbotti (6425198)
Simona Mastroianni (6425201)
Michela Cavallo (6425204)
Agostino Gnasso (739031)

March 2019

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p

Changes of clinical and laboratory parameters of the two groups during 12 months.

Masaaki Nakayama (496704)
Noritomo Itami (4433368)
Hodaka Suzuki (496709)
Hiromi Hamada (2148553)
Naoyuki Osaka (119691)
Ryo Yamamoto (2347003)
Kazumasa Tsunoda (4433365)
Hirofumi Nakano (1577305)
Kimio Watanabe (496706)
Wan-Jun Zhu (4433377)
Yukio Maruyama (829750)
Hiroyuki Terawaki (4433380)
Shigeru Kabayama (3738166)
Ryoichi Nakazawa (4433374)
Mariko Miyazaki (4433371)
Sadayoshi Ito (431945)

September 2017

Changes of clinical and laboratory parameters of the two groups during 12 months.</p

Body mass changes over the 4 months study period in CON, OVX and VIT-D groups (* indicates significance between CON and OVX groups, ** denotes significance between CON and VIT-D groups, † indicates significance between the OVX and VIT-D groups).

Andrew N. Luu (498343)
Lorenzo Anez-Bustillos (498344)
Shima Aran (498345)
Francisco J. Araiza Arroyo (498346)
Vahid Entezari (498347)
Claudio Rosso (498348)
Brian D. Snyder (498349)
Ara Nazarian (498350)

December 2013

Body mass changes over the 4 months study period in CON, OVX and VIT-D groups (* indicates signif...

Changes in the concentration of biochemical indicators among the participants during the follow-up period.

Łukasz Tota (6243731)
Anna Piotrowska (802338)
Tomasz Pałka (2806816)
Małgorzata Morawska (6243734)
Wioletta Mikuľáková (6243737)
Dariusz Mucha (1888993)
Magdalena Żmuda-Pałka (6243740)
Wanda Pilch (510885)

January 2019

Changes in the concentration of biochemical indicators among the participants during the follow-up p...

Clinical Characteristics of the study population at admission, by study groups.

Lena Novack (550638)
Slava Kogan (649285)
Larisa Gimpelevich (649286)
Michael Howell (228756)
Abraham Borer (649287)
Ciarán P. Kelly (5660920)
Daniel A. Leffler (649288)
Victor Novack (11880)

October 2014

Clinical Characteristics of the study population at admission, by study groups.</p

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) of Mf count/ml in blood for different treatment arms over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) ...

Demographic, clinical and biochemical characteristics of the study population.

Umayal Branavan (6166673)
Kajan Muneeswaran (6166676)
Sulochana Wijesundera (3713344)
Surangi Jayakody (6166679)
Vishvanath Chandrasekharan (4447165)
Chandrika Wijeyaratne (6166682)

December 2018

Demographic, clinical and biochemical characteristics of the study population.</p

Characteristics of the study subjects at baseline and at 21 months post-treatment.

Ivonne Martin (5616620)
Yenny Djuardi (236892)
Erliyani Sartono (161341)
Bruce A. Rosa (440552)
Taniawati Supali (161356)
Makedonka Mitreva (27680)
Jeanine J. Houwing-Duistermaat (188389)
Maria Yazdanbakhsh (90295)

August 2018

Characteristics of the study subjects at baseline and at 21 months post-treatment.</p

Changes in antigenemia (OG4C3) over period in the four arms:: Mean (SD) of log (OG4C) units for treatment over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Changes in antigenemia (OG4C3) over period in the four arms:: Mean (SD) of ...

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group I during six months of therapy.

Yi-Hua Lin (4385788)
Xi-Ning Liao (4385794)
Li-Li Fan (4385791)
Yue-Jin Qu (4385797)
De-Yun Cheng (4385800)
Yong-Hong Shi (4385803)

August 2017

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group I durin...

Anthropometric, clinical, and biochemical characteristics in study participants.

Ji-Young Seo (4524214)
Jae Hyun Kim (665252)

October 2017

Anthropometric, clinical, and biochemical characteristics in study participants.</p

Associations between percentage change in biomarkers and percentage change in body composition from randomisation to 48 weeks.

Jose I. Bernardino (6269696)
Amanda Mocroft (288350)
Cedrick Wallet (6269699)
Stéphane de Wit (3425663)
Christine Katlama (4926)
Peter Reiss (4933)
Patrick W. Mallon (6269702)
Laura Richert (713471)
Jean-Michel Molina (288240)
Hernando Knobel (312071)
Philippe Morlat (333147)
Abdel Babiker (225813)
Anton Pozniac (6269705)
Francois Raffi (6269708)
Jose R. Arribas (4053022)

January 2019

Associations between percentage change in biomarkers and percentage change in body composition from ...

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (OG4C3) units for treatment arms over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (...

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV during six months of therapy.

Yi-Hua Lin (4385788)
Xi-Ning Liao (4385794)
Li-Li Fan (4385791)
Yue-Jin Qu (4385797)
De-Yun Cheng (4385800)
Yong-Hong Shi (4385803)

August 2017

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV duri...

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.

Concetta Irace (739030)
Antonio Cutruzzolà (6425195)
Delia Francesca Carbotti (6425198)
Simona Mastroianni (6425201)
Michela Cavallo (6425204)
Agostino Gnasso (739031)

March 2019

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p

Changes of clinical and laboratory parameters of the two groups during 12 months.

Masaaki Nakayama (496704)
Noritomo Itami (4433368)
Hodaka Suzuki (496709)
Hiromi Hamada (2148553)
Naoyuki Osaka (119691)
Ryo Yamamoto (2347003)
Kazumasa Tsunoda (4433365)
Hirofumi Nakano (1577305)
Kimio Watanabe (496706)
Wan-Jun Zhu (4433377)
Yukio Maruyama (829750)
Hiroyuki Terawaki (4433380)
Shigeru Kabayama (3738166)
Ryoichi Nakazawa (4433374)
Mariko Miyazaki (4433371)
Sadayoshi Ito (431945)

September 2017

Changes of clinical and laboratory parameters of the two groups during 12 months.</p

Body mass changes over the 4 months study period in CON, OVX and VIT-D groups (* indicates significance between CON and OVX groups, ** denotes significance between CON and VIT-D groups, † indicates significance between the OVX and VIT-D groups).

Andrew N. Luu (498343)
Lorenzo Anez-Bustillos (498344)
Shima Aran (498345)
Francisco J. Araiza Arroyo (498346)
Vahid Entezari (498347)
Claudio Rosso (498348)
Brian D. Snyder (498349)
Ara Nazarian (498350)

December 2013

Body mass changes over the 4 months study period in CON, OVX and VIT-D groups (* indicates signif...

Changes in the concentration of biochemical indicators among the participants during the follow-up period.

Łukasz Tota (6243731)
Anna Piotrowska (802338)
Tomasz Pałka (2806816)
Małgorzata Morawska (6243734)
Wioletta Mikuľáková (6243737)
Dariusz Mucha (1888993)
Magdalena Żmuda-Pałka (6243740)
Wanda Pilch (510885)

January 2019

Changes in the concentration of biochemical indicators among the participants during the follow-up p...

Clinical Characteristics of the study population at admission, by study groups.

Lena Novack (550638)
Slava Kogan (649285)
Larisa Gimpelevich (649286)
Michael Howell (228756)
Abraham Borer (649287)
Ciarán P. Kelly (5660920)
Daniel A. Leffler (649288)
Victor Novack (11880)

October 2014

Clinical Characteristics of the study population at admission, by study groups.</p

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) of Mf count/ml in blood for different treatment arms over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) ...

Demographic, clinical and biochemical characteristics of the study population.

Umayal Branavan (6166673)
Kajan Muneeswaran (6166676)
Sulochana Wijesundera (3713344)
Surangi Jayakody (6166679)
Vishvanath Chandrasekharan (4447165)
Chandrika Wijeyaratne (6166682)

December 2018

Demographic, clinical and biochemical characteristics of the study population.</p

Characteristics of the study subjects at baseline and at 21 months post-treatment.

Ivonne Martin (5616620)
Yenny Djuardi (236892)
Erliyani Sartono (161341)
Bruce A. Rosa (440552)
Taniawati Supali (161356)
Makedonka Mitreva (27680)
Jeanine J. Houwing-Duistermaat (188389)
Maria Yazdanbakhsh (90295)

August 2018

Characteristics of the study subjects at baseline and at 21 months post-treatment.</p

Changes in antigenemia (OG4C3) over period in the four arms:: Mean (SD) of log (OG4C) units for treatment over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Changes in antigenemia (OG4C3) over period in the four arms:: Mean (SD) of ...

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group I during six months of therapy.

Yi-Hua Lin (4385788)
Xi-Ning Liao (4385794)
Li-Li Fan (4385791)
Yue-Jin Qu (4385797)
De-Yun Cheng (4385800)
Yong-Hong Shi (4385803)

August 2017

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group I durin...

Anthropometric, clinical, and biochemical characteristics in study participants.

Ji-Young Seo (4524214)
Jae Hyun Kim (665252)

October 2017

Anthropometric, clinical, and biochemical characteristics in study participants.</p

Associations between percentage change in biomarkers and percentage change in body composition from randomisation to 48 weeks.

Jose I. Bernardino (6269696)
Amanda Mocroft (288350)
Cedrick Wallet (6269699)
Stéphane de Wit (3425663)
Christine Katlama (4926)
Peter Reiss (4933)
Patrick W. Mallon (6269702)
Laura Richert (713471)
Jean-Michel Molina (288240)
Hernando Knobel (312071)
Philippe Morlat (333147)
Abdel Babiker (225813)
Anton Pozniac (6269705)
Francois Raffi (6269708)
Jose R. Arribas (4053022)

January 2019

Associations between percentage change in biomarkers and percentage change in body composition from ...

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (OG4C3) units for treatment arms over 24 months.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Changes in antigenemia (OG4C3) over period in the four arms: Mean (SD) of (...

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV during six months of therapy.

Yi-Hua Lin (4385788)
Xi-Ning Liao (4385794)
Li-Li Fan (4385791)
Yue-Jin Qu (4385797)
De-Yun Cheng (4385800)
Yong-Hong Shi (4385803)

August 2017

Changes in circulating biomarkers, pulmonary function and CAT scores of subjects in group IV duri...

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.

Concetta Irace (739030)
Antonio Cutruzzolà (6425195)
Delia Francesca Carbotti (6425198)
Simona Mastroianni (6425201)
Michela Cavallo (6425204)
Agostino Gnasso (739031)

March 2019

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p

Changes in clinical and biochemical characteristics at 24 months by study group.

Abstract

Extracted data

Changes in clinical and biochemical characteristics at 24 months by study group.

Abstract

Extracted data

Related items

Related items